Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments
04/10/2003WO2002050104A3 Methods and cells for detecting modulators of rgs proteins
04/10/2003WO2002048338A3 Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination
04/10/2003WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
04/10/2003WO2002044203A3 Production of recombinant bmp-2
04/10/2003WO2002040674A3 '67118', '67067' and '62092', human proteins and methods of use thereof
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002033058A3 Novel cysteine proteases and uses thereof
04/10/2003WO2002029034A3 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics
04/10/2003WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments
04/10/2003WO2002026980A3 Human ion-exchanger proteins and polynucleotides encoding t he same
04/10/2003WO2002022823A3 Proteins involved in the stress response and genes from ashbya gossypii coding for the same
04/10/2003WO2002018541A3 A neural specific cystosolic sulfotransferase for drug screening
04/10/2003WO2002012477A3 Enhanced replication of hcv rna
04/10/2003WO2002012294A3 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
04/10/2003WO2002012283A3 Disintegrin homologs, zsnk10, zsnk11, and zsnk12
04/10/2003WO2002010337A3 Method of cloning porcine animals
04/10/2003WO2002010202A3 G-protein coupled receptors and nucleic acids encoding same
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2002006533A3 Single primer pcr amplification of rna
04/10/2003WO2002003792A3 Transgenic mice containing targeted protease inhibitor gene disruptions
04/10/2003WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer
04/10/2003WO2001092547A9 Modified bovine adenovirus having altered tropism
04/10/2003WO2001087940A3 Polypeptide composionns toxic to anthonomus insects, and use thereof
04/10/2003WO2001083800A3 Heterologous production of polyketides
04/10/2003WO2001073014A9 Human survivin interacting protein 1 (sip-1)
04/10/2003WO2001068923A3 Mitochondrial dosimeter
04/10/2003WO2000018968A8 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
04/10/2003US20030070192 Generating trangenic plant; obtain cells, transform with vector containing preferential genes, propagate plants and express genes, monitor expression of metabolites
04/10/2003US20030070191 Transgenic fiber producing plants with increased expression of sucrose phosphate synthase
04/10/2003US20030070190 Methods for increasing stearate content in soybean oil
04/10/2003US20030070189 Transgenic corn plant for use in the generation of disease, pest, drought and stress resistant plants
04/10/2003US20030070188 Vanillin biosynthetic pathway enzyme from Vanilla planifolia
04/10/2003US20030070186 Mammalian cells for use as tools in animal cloning
04/10/2003US20030070185 Animal model for use in the generation of preferential antibodies
04/10/2003US20030069701 DNA chip technique for identifying multiple kinds of DNA contained in a target
04/10/2003US20030069700 Fab fragment crystal containing BC2 complementarity determining regions (CDRs).
04/10/2003US20030069411 Apparatus for use in the generation of preferential oligonucleotide
04/10/2003US20030069409 T1-R ligand III
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069405 70 human secreted proteins
04/10/2003US20030069403 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069398 Identification of human gaba transporter
04/10/2003US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/10/2003US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069196 Ameliorating a symptom of an ischemic disorder or injury comprising administering a 200 gene product to ameliorate the symptom of the ischemic disorder or injury.
04/10/2003US20030069195 Suppression of polymorphic alleles
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030069173 Peptide-enhanced transfections
04/10/2003US20030068821 Method for expression of small RNA molecules within a cell
04/10/2003US20030068818 Animal tissue with carbohydrate antigens compatible for human transplantation and a carbohydrate determinant selection system for homologous recombination
04/10/2003US20030068817 Tubularized tissue; for use in the treatment of hypoxia, vascular necrosis, foot ulcer diabetes, athersclerosis, stroke, wounds and bone fractures
04/10/2003US20030068811 Generation of therapeutic agent for the treatment of alzheimer's disease; obtain chemical intermediates, reduce with oxidoreductase, recover therapeutic agent
04/10/2003US20030068810 Method for removing endotoxins
04/10/2003US20030068808 Methods for generating antibiotic resistant microbes and novel antibiotics
04/10/2003US20030068807 Precursor conversion screening methods
04/10/2003US20030068806 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
04/10/2003US20030068805 Glucanase for use in food processing
04/10/2003US20030068801 Beetle luciferase for use as diagostic tool in genetic engineering
04/10/2003US20030068799 Recombinational cloning using engineered recombination sites
04/10/2003US20030068798 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068797 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068796 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068795 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068794 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/10/2003US20030068793 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068788 Nucleotide sequences coding enzymatic polypeptide for use in biological pest control
04/10/2003US20030068785 Modified factor VIII
04/10/2003US20030068784 Peptide for use in the diagnosis and treatment of cardiovascular disorders
04/10/2003US20030068776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068775 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068774 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068773 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068772 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068768 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068767 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068766 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068762 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068761 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068759 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068758 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068757 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068756 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068755 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068754 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068753 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068752 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068751 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030068750 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068749 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
04/10/2003US20030068748 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 ... 4023